SJP1901 / Samjin Pharma - LARVOL DELTA

[VIRTUAL] SJP1901, a small molecule inhibitor targeting hippo pathway by directly inhibiting TEAD palmitoylation in hippo pathway-dependent cancer (AACR 2021) - "SJP1901 showed outstanding anti-cancer effects through regulating hippo pathway-mediated target genes and lower toxicitiy in normal cells. In vivo efficacy study and research to expand the indications are currently ongoing."

Lung Cancer • Mesothelioma • Oncology • Solid Tumor • CTGF